A POLYMYOSITIS AFTER mRNA COVID-19 VACCINATION CASE REPORT
DOI:
https://doi.org/10.21776/ub.mnj.2024.010.02.14Keywords:
COVID-19, vaccination, polymyositisAbstract
Polymyositis is a rare, acquired, and inflammatory muscular disease, which is characterized by the inflammation of muscles and has no known etiology. The autoimmunity created by the vaccine arose from molecular mimicking or directly by vaccine adjuvants. Polymyositis cases were reported after hepatitis B, influenza A (H1N1), tetanus toxoid, and Bacille Calmette-Guerin (BCG) vaccinations. However, no relationship with COVID-19 vaccination has been reported yet. Myositis and dermatomyositis cases have been seen after covid-19 vaccine. m-RNA COVID-19 vaccines might cause abnormal activation of the immune system due to a strong t-cell-mediated immune activation by vaccinesin the present case, without any additional triggering factor, a case diagnosed with polymyositis developing 10 days after the second dose of messenger RNA (mRNA) COVID-19 vaccine is presented. The findings suggest a potential association between mRNA COVID-19 vaccination and the development of polymyositis, prompting further investigation into this rare occurrence.
Downloads
References
Saud A, Naveen R, Aggarwal R, Gupta L. COVID-19 and myositis: What we know so far. Curr Rheumatol Rep; 2021. Jul 3;23(8):63.
DOI: 10.1007/s11926-021-01023-9
Tanboon J, Nishino I. COVID-19-associated myositismay be dermatomyositis. Muscle Nerve; 2021. Jan;63(1):E9-E10.
DOI: 10.1002/mus.27105. Epub 2020 Nov 15
Dalakas MC. Inflammatorymyopathies: Update on diagnosis, pathogenesisandtherapies, and COVID-19-related implications. ActaMyol; 2020. Dec 1;39(4):289-301.
DOI: 10.36185/2532-1900-032
Qian J, Xu H. COVID-19 diseaseand dermatomyositis: A mini-review. Front Immunol; 2022. Jan 3;12:747116.
DOI: 10.3389/fimmu.2021.747116. eCollection 2021.
Stübgen JP. A review on the association between inflammatory myopathies and vaccination. Autoimmun Rev; 2014. Jan;13(1):31-9.
DOI: 10.1016/j.autrev.2013.08.005
Orbach H, Tanay A. Vaccines as a trigger for myopathies. Lupus; 2009. Nov;18(13):1213-6.
DOI: 10.1177/0961203309345734.
Ferri C, Colaci M, Manzini CU, Sebastiani M, Giuggioli D, Brugioni L. Poly myositis following pandemic influenza A (H1N1) and seasonal trivalent vaccines. Case Rep Rheumatol; 2012. 2012:836930. DOI: 10.1155/2012/836930.
Ramírez-Rivera J, Vega-Cruz AM, Jaume-Anselmi F. Polymyositis: Rarecomplication of hepatitis B vaccination. An unusualcause of toxicshocksyndrome. Bol AsocMed P R; 2003. Nov-Dec;95(6):13-6.PMID: 15449786.
Conticini E, d'Alessandro M, Grazzini S, Fornaro M, Sabella D, Lopalco G, Giardina F, Colafrancesco S, Rizzo C, Guggino G, Priori R, Conti F, Iannone F, Bargagli E, Cantarini L, Frediani B. Relapses of idiopathic inflammatory myopathies after vaccination against COVID-19: A real-life multicenter Italian study. Intern Emer gMed; 2022. Jun26:1–8. DOI: 10.1007/s11739-022-03028-3
Gouda W, Albasri A, Alsaqabi F, Al Sabah HY, Alkandari M, Abdelnaby H. Dermato myositis following BNT162b2 mRNA COVID-19 vaccination. J Korean Med Sci; 2022. Feb 7;37(5):e32.
DOI: 10.3346/jkms.2022.37.e32.
Venkateswaran K, Aw DC, Huang J, Angkodjojo S. Dermato myositis following COVID-19 vaccination. Dermatol Ther; 2022. Jun;35(6):e15479.
DOI: 10.1111/dth.15479. Epub 2022 Apr 7.
Pakhchanian H, Saud A, Raiker R, Kardes S, Aggarwal R, Gupta L. COVID-19 vaccination outcomes among patients with dermatomyositis: A multicentered analysis. Clin Rheumatol; 2022. Jul;41(7):2257-2260
DOI: 10.1007/s10067-022-06081-7
Jaroslaw J. Fedorowski. Could amantadine possibly interfere with COVID-19 vaccines based on LNP-mRNA platform ?; Arch Med Sci; 2021. 17(3):827–828. DOI: 10.5114/aoms/134716
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 MNJ (Malang Neurology Journal)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
